Schistosomiasis project gets $1.15M boost from Gates Foundation

08/26/2013 | Pharmaceutical Business Review Online

An international public-private partnership that aims to develop a pediatric treatment for schistosomiasis, or bilharzia, received a $1.15 million grant from the Bill & Melinda Gates Foundation. Members of the consortium include Astellas Pharma, Merck KGaA and the Swiss Tropical and Public Health Institute.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA